Sygnature Discovery

JULY 31, 2023

This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market leader. Previous acquisitions made were Peak Proteins in April 2022 and SB Drug Discovery in January 2023.

Computational Chemistry 52

Computational Chemistry Science Clinical Trials Pharmaceutical Companies 52

Drug Target Review

SEPTEMBER 20, 2023

Matthew subsequently put his computational chemistry skills to use in the defence sector. Following a second stint in defence, he joined Cresset in 2022, working to develop, source and evaluate new computational techniques for Cresset’s software. Rob is a Fellow of the Royal Society of Chemistry.

Drugs 105

Drugs Metabolic Stability Computational Chemistry Pharmaceuticals 105

LifeSciVC

APRIL 27, 2023

The premise at the time was that putting computational chemistry in the primary position for new molecule ideation would upend the drug discovery paradigm. set up a “virtual project team,” leverage Schrödinger scientists to lead computational chemistry, and do all the wet work at CROs. It did just that.

Small Molecule 40

Small Molecule Computational Chemistry Engineering Clinical Development 40